Kevin Michael Mullins - 25 Apr 2022 Form 4 Insider Report for LifeStance Health Group, Inc. (LFST)

Role
Chief Development Officer
Signature
By: /s/ Ryan Pardo, Attorney-in-Fact
Issuer symbol
LFST
Transactions as of
25 Apr 2022
Transactions value $
$0
Form type
4
Date filed
26 Apr 2022, 17:14
Previous filing
22 Apr 2022
Next filing
14 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFST Common Stock Award $0 +76.4K +1.35% $0.00 5.75M 25 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 76,446 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.